magnus wallberg november 24 th 2009 dar es salaam, tanzania [email protected] who-art

20
Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who- umc.org WHO-ART

Upload: rosaline-parsons

Post on 22-Dec-2015

220 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg

November 24th 2009Dar Es Salaam, Tanzania

[email protected]

WHO-ART

Page 2: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART(WHO-Adverse Reaction Terminology)

Page 3: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

The need for a medical terminologydyspnoea ? tinnitus ARDS

fever feeling high

mood swings breath shortness

? unconsciousness

heart disorder headache

SOB somnolence rash

Page 4: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

General requirements

Data entry:

• comprehensive• specific• consistent• user friendly

Data retrieval:

• flexible• accurate• consistent• user friendly

Other:

• multilingual• definitions• computer

adaptation• continous

updating

Page 5: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART

Developed for the WHO Drug Monitoring Programme

• in use for 40 years• for adverse reaction monitoring

– NOT for indications, tests, background diseases etc.

• used by both regulatory agencies and pharmaceutical manufacturers

• maintained by the UMC

Page 6: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART cont.

• 4 level hierarchial structure

• New terms added when necessary

• Created in English

• Translations in French, German, Italian, Spanish,

Portuguese (Chinese, Japanese, Korean, Russia)

• Paper print, CD and electronical version

• Latest version available in VigiSearch (and

VigiFlow)

Page 7: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART hierarchy

Preferred Term(PT)

High level term(HLT)

System Organ Class(SOC)

Included Term(IT)

group of preferred terms pertaining to the same bodyorgan (32*)

group of similar preferred terms (184*)

principal terms for coding and presentation (2158*)

terms similar topreferred terms(3607*)

*May 2008

Page 8: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART hierarchy- an example

PTArthropathy

HLTArthropathy

SOCMusculo-skeletal system disorders

ITJoint

dysfunction

PTArthritis

ITPolyarthropathy

ITJoint

inflammation

ITOsteoarthritis

Page 9: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART hierarchy

- example II

Page 10: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

Complete list of System Organ Classes

Skin and appendages disorders 0100Musculo-skeletal system disorders 0200Collagen disorders 0300Central & peripheral nervous system disorders

0410Autonomic nervous system disorders 0420Vision disorders 0431Hearing and vestibular disorders 0432Special senses other, disorders 0433Psychiatric disorders 0500Gastro-intestinal system disorders 0600Liver and biliary system disorders 0700Metabolic and nutritional disorders 0800Endocrine disorders 0900Cardiovascular disorders, general 1010Myo-, endo-, pericardial & valve disorders 1020Heart rate and rhythm disorders 1030Vascular (extracardiac) disorders 1040Respiratory system disorders 1100Red blood cell disorders 1210White cell and RES* disorders 1220Platelet, bleeding & clotting disorders 1230Urinary system disorders 1300Reproductive disorders, male 1410Reproductive disorders, female 1420Foetal disorders 1500Neonatal and infancy disorders 1600Neoplasms 1700Body as a whole - general disorders 1810Application site disorders 1820Resistance mechanism disorders 1830

Secondary terms - events 2000Poison specific terms 2100

* RES - Reticuloendothelial system

Page 11: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ARTSystem Organ Classes

Skin and appendages disorders

Musculo-skeletal system disorders

Collagen disorders

etc...

Secondary terms

events not likely to be a direct effect of a drug, e.g. medication error, wound infection, burn, fall

Poison terms

e.g. foetal alcohol syndrome, silicosis, chemical burn

0100

0200

0300

etc...

2000

2100

Page 12: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART - Critical termsDefinition;A subset of adverse reaction terms

referringto, or possibly being indicative of, seriousdisease states, which have been regarded

asparticularly important to monitor

e.g. Death, anaphylactic shock, convulsions, erythema

multiforme

Page 13: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

WHO-ART summary

• WHO-ART makes it easy to sort and search information on ADRs

• 4 level hierarchial structure– Preferred terms are the principle terms for coding

and output

• Multilingual

• Critical terms list for focus on more serious outcomes

Page 14: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Magnus Wallberg, UMC

But... what about MedDRA

Page 15: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Features of MedDRA in comparison to WHO-ART

• More terms in MedDRA– More fine granular – Easier to give correct description of a reaction

• More levels in MedDRA– Other interesting levels for statistical analysis

• SMQs (Standardized MedDRA Queries)– To simplify analysis when using MedDRA

• ICH MedDRA Points-to-Consider Documents– Developed to facilitate consistent input and output

Page 16: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Structure comparison

SOC

HLT

PT

IT

WHO-ART

SOC

HLT

HLGT

PT

LLT

MedDRA

SMQ

Page 17: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

Content and mapping comparison

MedDRA

WHO-ART

Page 18: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

MedDRA/WHO-ART grouping• Given the differences, how can MedDRA and

WHO-ART be used in parallel– Reports are always coded on PT/LLT level, same as

for WHO-ART where PT/IT is used – Multiple MedDRA terms can correspond to the

same WHO-ART term (and in rare cases vice versa)– Some MedDRA terms representing indications, non

ADR events and laboratory tests must be mapped to a generic WHO-ART term

The above considerations result in what we call a “Grouping Structure” !

Page 19: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

MedDRA grouping structure

WHO-ART view

2 reports

1 term

MedDRA view

2 reports

2 terms

WA2

WA1

WA3

WA4

WA5

M2

M3

M1

M5

M6

M4

M7

M8

Report1 Report2

Page 20: Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org WHO-ART

WHO Collaborating Centre for International Drug Monitoring

Box 1051, SE - 751 40 Uppsala Sweden Tel +46 18 65 60 60, Fax +46

18 65 60 88 E-mail: [email protected]

Website: www.who-umc.org